Director Jesper Hoeiland joins Allarity Therapeutics (ALLR) with initial Form 3 filing
Rhea-AI Filing Summary
Allarity Therapeutics filed an initial ownership report for director Jesper Hoeiland. This Form 3 identifies Hoeiland as a director of Allarity Therapeutics, Inc. and serves as his initial statement of beneficial ownership in the company’s securities. The filing does not list any reportable transactions or derivative positions at this time.
Positive
- None.
Negative
- None.
Key Terms
Form 3, beneficial ownership, reporting person
3 terms
Form 3 regulatory
"This Form 3 identifies Hoeiland as a director of Allarity Therapeutics, Inc."
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"serves as his initial statement of beneficial ownership in the company’s securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
reporting person regulatory
"It formally records his status as a reporting person under SEC rules"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Allarity Therapeutics (ALLR) Form 3 for Jesper Hoeiland show?
The Form 3 identifies Jesper Hoeiland as a director of Allarity Therapeutics, Inc. It serves as his initial statement of beneficial ownership, with no specific transactions or holdings detailed in the summarized data.
Does the ALLR Form 3 report any stock purchases or sales by Jesper Hoeiland?
The summarized Form 3 data shows no reported transactions by Jesper Hoeiland. Buy, sell, exercise, gift, tax withholding, and restructuring counts are all listed as zero in the transaction summary.
Are any derivative securities reported for Jesper Hoeiland in Allarity Therapeutics’ Form 3?
The derivative section for Jesper Hoeiland is empty in this Form 3 snapshot. The derivativeSummary shows no options or other derivative positions reported as of this filing’s disclosure.
What is the purpose of this Allarity Therapeutics (ALLR) Form 3 filing?
This Form 3 functions as an initial beneficial ownership statement for director Jesper Hoeiland. It formally records his status as a reporting person under SEC rules, even though no specific holdings or transactions are listed here.
Does the ALLR Form 3 indicate Jesper Hoeiland is a 10% owner of Allarity Therapeutics?
The Form 3 data flags Jesper Hoeiland as a director but not as a 10% owner. The is_ten_percent_owner field is set to zero, indicating he is not reported as owning 10% or more of the company’s stock.